News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Late-Stage Biotech Relypsa, Inc. Seeks $138 Million in Upsized IPO


10/18/2013 8:24:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Relypsa, a late-stage biotech developing treatments for renal, cardiovascular and metabolic diseases, raised its deal size to $138 million and announced it will list under the ticker RLYP on Thursday. The Redwood City, CA-based company had previously filed to raise up to $127 million.elypsa was founded in 2007 and plans to list on the NASDAQ.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq

comments powered by Disqus
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES